Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-03T00:58:46.541Z Has data issue: false hasContentIssue false
  • English
  • Français

Current Practices and the Provider Perspectives on Inconclusive Genetic Test Results for Osteogenesis Imperfecta in Children with Unexplained Fractures: ELSI Implications

Published online by Cambridge University Press:  01 January 2021

Emily Youngblom ,
Mitzi Leah Murray  and
Peter H. Byers
Get access Rights & Permissions [Opens in a new window]

Abstract

Genetic testing can be used to determine if unexplained fractures in children could have resulted from a predisposition to bone fractures, e.g., osteogenesis imperfecta. However, uncertainty is introduced if a variant of unknown significance (VUS) is identified. Proper interpretation of VUS in these situations is critical because of its influence on clinical care and in court rulings. This study sought to understand how VUS are interpreted and used by practitioners when there is a differential diagnosis including both osteogenesis imperfecta and non-accidental injury.

A 15-question survey was emailed to physicians who requested analysis of two genes, COL1A1 and COL1A2, from the University of Washington from 2005-2013 for patient cases involving suspicion of child abuse.

Among the 89 participants, responses differed about when genetic testing should be ordered for osteogenesis imperfecta, who should be consulted about utilization of VUS test results, follow-up procedures, and who should receive the VUS results.

There are no clear guidelines for how to interpret and follow up on VUS. In the legal setting, misinterpreted VUS could lead to unintended consequences and deleterious ramifications for family members. The need for better practice guidelines to help promote more equitable handling of these sensitive legal cases is clear.

Type
Independent Articles
Information
Journal of Law, Medicine & Ethics , Volume 44 , Issue 3: Contemporary Challenges in Informed Consent: Law, Research Practice, and Ethics , Fall 2016 , pp. 514 - 519
Copyright
Copyright © American Society of Law, Medicine and Ethics 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wardinsky, T. D., “Genetic and Congenital Defect Conditions That Mimic Child Abuse,” Journal of Family Practice 41, no. 4 (1995): 377–383.Google Scholar
Sillence, D. O., Senn, A., and Danks, D. M., “Genetic Heterogeneity in Osteogenesis Imperfecta,” Journal of Medical Genetics 16, no. 2 (1979): 101–116.Google Scholar
Marlowe, A., Pepin, M. G., and Byers, P. H., “Testing for Osteo-genesis Imperfecta in Cases of Suspected Non-accidental Injury,” Journal of Medical Genetics 39, no. 6 (2002): 382–386.Google Scholar
Leventhal, J. M., Martin, K. D., and Asnes, A. G., “Incidence of Fractures Attributable to Abuse in Young Hospitalized Children: Results from Analysis of a United States Database,” Pediatrics 122, no. 3 (2008): 599–604.Google Scholar
See Leventhal, supra note 4.Google Scholar
See Marlowe, supra note 3.Google Scholar
Tinkle, B. T. and Wenstrup, R. J., “A Genetic Approach to Fracture Epidemiology in Childhood,” American Journal of Medical Genetics Part C: Seminars in Medical Genetics 139c., no. 1 (2005): 38–54.CrossRefGoogle Scholar
University of Leicester, “Osteogenesis Imperfecta & Ehlers-Danlos Syndrome Variant Databases,” available at <http://www.le.ac.uk/ge/collagen/> (last visisted July 18, 2016); R. Dalgleish, “The Human Type I Collagen Mutation Database,” Nucleic Acids Research 25 (1997): 181-187; R. Dalgleish, “The Human Collagen Mutation Database,” Nucleic Acids Research 26 (1998): 253–255.+(last+visisted+July+18,+2016);+R.+Dalgleish,+“The+Human+Type+I+Collagen+Mutation+Database,”+Nucleic+Acids+Research+25+(1997):+181-187;+R.+Dalgleish,+“The+Human+Collagen+Mutation+Database,”+Nucleic+Acids+Research+26+(1998):+253–255.>Google Scholar
Valadares, E. R., Carneiro, T. B., Santos, P. M., Oliveira, A. C., and Zabel, B., “What Is New in Genetics and Osteogenesis Imperfecta Classification?” Journal of Pediatrics (Rio J) 90, no. 6 (2014): 536–541.Google Scholar
van Dijk, F. S., Byers, P. H., Dalgleish, R., Malfait, F., Maugeri, A., and Rohrbach, M. et al., “EMQN Best Practice Guidelines for the Laboratory Diagnosis of Osteogenesis Imperfecta,” European Journal of Human Genetics 20, no. 1 (2012): 11–19.Google Scholar
Proost, D., Vandeweyer, G., Meester, J. A., Salemink, S., Kempers, M., and Ingram, C. et al., “Performant Mutation Identification using Targeted Next Generation Sequencing of Fourteen Thoracic Aortic Aneurysm Genes,” Human Mutations 36, no. 8 (2015): 808-814; W. Wooderchak-Donahue, C. VanSant-Webb, T. Tvrdik, P. Plant, T. Lewis, and J. Stocks et al., “Clinical Utility of a Next Generation Sequencing Panel Assay for Marfan and Marfan-Like Syndromes Featuring Aortopathy,” American Journal of Medical Genetics-Part A 167A no. 8 (2015): 1747–1757.Google Scholar
Matter of Maria S. (Samantha S.) Decided April 29, 2014. NY Slip Op 50690(U), New York State Law Reporting Bureau pursuant to Judiciary Law § 431 Justia Law, available at <http://law.justia.com/cases/new-york/other-courts/2014/2014-ny-slip-op-50690-u.html> (last visited July 18, 2016).+(last+visited+July+18,+2016).>Google Scholar
See Marlowe et al., supra note 3.Google Scholar
Hsieh, H. F., and Shannon, S. E., “Three Approaches to Qualitative Content Analysis,” Qualitative Health Research 15 (2005): 1277–1288.CrossRefGoogle Scholar
American Society of Human Genetics (ASHG) Member Directory Search, available at <http://www.ashg.org/pages/member_search.shtml> (last visted July 18, 2016).+(last+visted+July+18,+2016).>Google Scholar
Snyder, L. and the American College of Physicians Ethics, Professionalism, and Human Rights Committee, “American College of Physicians Ethics Manual, 6th Edition,” Annals of Internal Medicine 156 (2012): 73–104.CrossRefGoogle Scholar